issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged share capital (the “Share Purchase”) at the price of INR 36 per share. The Company would
Baht 292.12 million in the amount of Baht 37 million or a from decrease of 11.24 percent as a result of the Company's marketing policy to expand its market share. (Market Share) by adjusting the price
by its indirect subsidiary Indorama Netherlands B.V. (“INBV”) of 83,000,000 newly issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged
consolidated revenues have increased to Baht 360.4 and Baht 797.3 million, a 0.8% and 11.8% growth over same period of last year with details as the followings: - The revenues for 2nd-quarter and 6-month
same period last year. The company has adjusted its marketing policy. By restructuring work teams, sales and marketing increased. In addition, the Company has expanded its sales in the modern retail and
increased. And the company has expanded its sales in both modern retailers and department stores, resulting in an increase in sales related expenses. Expenses January – June 2017 January – June 2016 Increase
holders of the Company 28.2 million baht the same period last year, loss increased 60.5 million baht or 214.5 percent. If excluding provisions for employee benefits according to Labor Protection Act No. 7
or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In
in the amount of 15.97 million baht or 5.47 percent as a result of the company adjusting the marketing policy to expand the market share by adjusting the sales price decreased And increased trade